Article info
PDFClinical science
Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial
- Correspondence to Dr R C Preti, Division of Ophthalmology, University of São Paulo Medical School, Av Ramalho Ortigão, 269 apartamento 54—Vila Gumercindo, São Paulo 04130010, Brazil; preti{at}usp.br
Citation
Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial
Publication history
- Received October 3, 2012
- Revised April 1, 2013
- Accepted April 14, 2013
- First published May 17, 2013.
Online issue publication
June 12, 2013
Article Versions
- Previous version (17 May 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions